Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17133 | 552 | 33.9 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
103 | 24571 | PARA TUBERCULOSIS//MYCOBACTERIUM BOVIS//JOHNES DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MYCOBACTERIOPHAGE L1 | Author keyword | 17 | 100% | 1% | 8 |
2 | RECOMBINANT BCG VACCINE | Author keyword | 6 | 80% | 1% | 4 |
3 | RECOMBINANT BCG | Author keyword | 6 | 30% | 3% | 16 |
4 | MYCOBACTERIOPHAGE | Author keyword | 6 | 38% | 2% | 12 |
5 | PAL5000 | Author keyword | 6 | 100% | 1% | 4 |
6 | PITTSBURGH BACTERIOPHAGE | Address | 5 | 25% | 3% | 19 |
7 | SLOW GROWING MYCOBACTERIA | Author keyword | 3 | 60% | 1% | 3 |
8 | CATALAN HIV VACCINE DEV | Address | 2 | 67% | 0% | 2 |
9 | FOREIGN ANTIGENS | Author keyword | 2 | 67% | 0% | 2 |
10 | IDIB S HIVACAT | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MYCOBACTERIOPHAGE L1 | 17 | 100% | 1% | 8 | Search MYCOBACTERIOPHAGE+L1 | Search MYCOBACTERIOPHAGE+L1 |
2 | RECOMBINANT BCG VACCINE | 6 | 80% | 1% | 4 | Search RECOMBINANT+BCG+VACCINE | Search RECOMBINANT+BCG+VACCINE |
3 | RECOMBINANT BCG | 6 | 30% | 3% | 16 | Search RECOMBINANT+BCG | Search RECOMBINANT+BCG |
4 | MYCOBACTERIOPHAGE | 6 | 38% | 2% | 12 | Search MYCOBACTERIOPHAGE | Search MYCOBACTERIOPHAGE |
5 | PAL5000 | 6 | 100% | 1% | 4 | Search PAL5000 | Search PAL5000 |
6 | SLOW GROWING MYCOBACTERIA | 3 | 60% | 1% | 3 | Search SLOW+GROWING+MYCOBACTERIA | Search SLOW+GROWING+MYCOBACTERIA |
7 | FOREIGN ANTIGENS | 2 | 67% | 0% | 2 | Search FOREIGN+ANTIGENS | Search FOREIGN+ANTIGENS |
8 | IS1096 | 2 | 67% | 0% | 2 | Search IS1096 | Search IS1096 |
9 | MYCOBACTERIOPHAGES | 2 | 43% | 1% | 3 | Search MYCOBACTERIOPHAGES | Search MYCOBACTERIOPHAGES |
10 | LAWRIST4 | 1 | 100% | 0% | 2 | Search LAWRIST4 | Search LAWRIST4 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COLI SHUTTLE VECTOR | 21 | 73% | 3% | 16 |
2 | PAL5000 | 15 | 67% | 3% | 14 |
3 | BOVIS BCG DNA | 12 | 86% | 1% | 6 |
4 | EXPRESSING FIREFLY LUCIFERASE | 8 | 100% | 1% | 5 |
5 | OSPA LIPOPROTEIN | 6 | 80% | 1% | 4 |
6 | LYME DISEASE VACCINE | 6 | 41% | 2% | 11 |
7 | LUCIFERASE REPORTER PHAGES | 5 | 34% | 2% | 12 |
8 | A OSPA LIPOPROTEIN | 4 | 67% | 1% | 4 |
9 | ORIGIN BINDING ACTIVITY | 4 | 75% | 1% | 3 |
10 | SLOW GROWING MYCOBACTERIA | 4 | 75% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Recombinant Mycobacterium bovis BCG | 2009 | 29 | 117 | 40% |
Mycobacteriophages: Genes and Genomes | 2010 | 28 | 85 | 45% |
Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines | 2005 | 40 | 104 | 47% |
The Secret Lives of Mycobacteriophages | 2012 | 14 | 158 | 38% |
Recombinant BCG vaccines | 2001 | 48 | 78 | 47% |
INNOVATION Recombineering mycobacteria and their phages | 2008 | 32 | 60 | 28% |
Progress towards an HIV vaccine based on recombinant Bacillus Calmette-Guerin: failures and challenges | 2006 | 11 | 51 | 59% |
GENETIC SYSTEMS FOR MYCOBACTERIA | 1991 | 327 | 9 | 56% |
On the nature of mycobacteriophage diversity and host preference | 2012 | 13 | 63 | 24% |
Mycobacterial promoters | 1997 | 54 | 103 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PITTSBURGH BACTERIOPHAGE | 5 | 25% | 3.4% | 19 |
2 | CATALAN HIV VACCINE DEV | 2 | 67% | 0.4% | 2 |
3 | IDIB S HIVACAT | 2 | 67% | 0.4% | 2 |
4 | BCG | 2 | 25% | 1.3% | 7 |
5 | HOSP CLIN IDIB S HIVACAT | 1 | 50% | 0.4% | 2 |
6 | ARTMENT MICROBIOL | 1 | 50% | 0.2% | 1 |
7 | BIOL AGENTS | 1 | 50% | 0.2% | 1 |
8 | IMMUNOBIOL TECHNOL | 1 | 50% | 0.2% | 1 |
9 | NHLSWITS MOL MYCOBACTERIOL UNIT | 1 | 50% | 0.2% | 1 |
10 | PL MOL BIOL PHARMACOGEN | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000264391 | DEVR//PE_PGRS//MOL MYCOBACTERIOL UNIT |
2 | 0.0000168721 | GLYCOPEPTIDOLIPID//GLYCOPEPTIDOLIPIDS//PGPL MC |
3 | 0.0000158705 | CAS 58001 44 8//HOSPITAL PATHOGENS//RV3676 |
4 | 0.0000119693 | ANTIGEN 60//38 KDA ANTIGEN//16 KDA ANTIGEN |
5 | 0.0000094248 | BCG//TUBERCULOSIS//LANZHOU TB |
6 | 0.0000086873 | RECOMBINEERING//LAMBDA RED//LAMBDA RED RECOMBINATION |
7 | 0.0000076388 | Z 100//BCG VIABILITY//NATURAL IMMUNOMODULATOR |
8 | 0.0000073082 | PHAGE THERAPY//BACTERIOPHAGE//BACTERIOPHAGE THERAPY |
9 | 0.0000069372 | SITE SPECIFIC RECOMBINATION//SERINE RECOMBINASE//PHI C31 INTEGRASE |
10 | 0.0000058461 | LINEAR PLASMID//LINEAR CHROMOSOME//PUR CLUSTER |